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BACKGROUND: Congenital rubella syndrome (CRS) affects  
thousands of children in the developing world 
because rubella vaccination is not routinely available in most of 
these countries. Among its many manifestations, congenital heart 
disease is life threatening.  
CASE DETAILS: A 9-month-old infant presented with whitish 
lesions over her left eye. She was evaluated with echocardiography 
that revealed peripheral pulmonary stenosis and patent ductus 
arteriosus. She had severe acute malnutrition and clinically 
confirmed congenital rubella syndrome (CRS). There was no 
available serologic test to confirm the diagnosis.  
CONCLUSION: This case was presented to demonstrate typical 
dual features of CRS by echocardiography and to emphasize the 
benefit of vaccination to prevent deleterious complications from 
congenital rubella syndrome.  





The name rubella is derived from a Latin term meaning "little red". 
Rubella is generally a benign, communicable and exanthematous 
disease. It is caused by rubella virus, which is a member of the 
Rubivirus genus of the family Togaviridae.  Rubella is characterized 
by a mild, maculopapular rash. However, up to 50% of rubella 
infections are subclinical, sometimes misdiagnosed as measles or 
scarlet fever (1).   
In 2014, 141 CRS cases were reported from 114 countries 
mostly from Southeast Asia (n = 86/141). Therefore, the authors felt 
that the reporting may be inconsistent, as it is estimated that each 
developing country experiences an incidence of 100,000 cases per 
year alone (2). 
Rubella virus is generally acquired by airborne distribution and 
enters the maternal respiratory tract (1). It is often so difficult to 
verify rubella exposure during pregnancy in postpartum mothers who 
may have actually had such a mild, 
subclinical infection that it remained 
unrecognized. 
The fetus acquires rubella through the course 
of pregnancy. The clinical significance depends on 
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the time of the mother’s acquisition of the virus. If 
maternal infection happens to be in the first 
trimester, the risk of rubella-associated defects is 
greatly increased. According to Pumper and 
Yamashiroya, between 50% and 80% of fetuses 
exposed to maternal rubella virus become infected 
prior to the 8
th
 weeks of gestation. Infection of the 
fetus is fairly uncommon, during the 3
rd
 trimester 
which is 6%-10% (3). The eyes, the ears, the 
heart, the central nervous system and the brain 
appear to be especially susceptible to rubella-
associated damage (4).  
When maternal rubella is present, the virus 
spreads through the placenta and in to the fetus. In 
the placenta, the chorionic tissues are the most 
affected. They experience necrosis of the 
epithelium and fragmentation of the small blood 
vessels. The virus may spread to fetal tissues via 
infected emboli or direct damage to the small fetal 
blood vessels. The virus resides in the cell’s 
nucleus as clones or group of cells, as 
demonstrated by fluorescent antibody technique 
(5).  
Severe rubella virus infection, acquired in 
utero early in pregnancy, is named as Congenital 
Rubella Syndrome (CRS).   It refers to variable 
constellations of birth defects (for example, 
hearing impairment, congenital heart defects, 
cataracts or congenital glaucoma, pigmentary 
retinopathy, etc). WHO developed clinical criteria 
to classify CRS as either Suspected CRS case, 
Clinically Confirmed CRS case, Laboratory 
Confirmed CRS Case or Congenital Rubella 
Infection (CRI) (6).  
Previous studies focused on the CRS triads: 
hearing impairments, cataracts and congenital 
heart disease (7). Later, the distinguishing CRS 
features expanded to include low birth weight and 
delayed neonatal growth, thrombocytopenic 
purpura, transient bone lesions, anemia, hepatitis, 
microcephaly, psychomotor retardation and other 
disorders(5, 8, 9).  
Rubella virus antigens were detected in 
myocardial fibroblasts of two patients, although 
they did not have histological signs of myocarditis 
or viral antigens in their cardiac myocytes (10). 
Additional evidence of the presence of viral 
antigens in adventitial fibroblasts of large blood 
vessels helps explain the possible mechanisms for 
congenital cardiovascular malformations (patent 
ductus arteriosus and branch pulmonary artery 
stenosis) in CRS patients. This evidence 
potentially excludes the prior thoughts about the 
cytolytic injury of cardiac myocytes and more 
likely suggests a disturbance of the normal 
development of the cardiovascular system through 
cardiac fibroblasts infection. These fibroblasts 
normally form structural scaffolding for the 
attachment of cardiac cell types during 
development, express growth factors and 
cytokines, and regulate proliferation of embryonic 
cardiomyocytes (11).  
 
In summary, although the mechanisms by 
which rubella virus causes fetal damage are poorly 
understood; the defects observed are likely 
secondary to vasculitis resulting in tissue necrosis 
without inflammation. Another possible 
mechanism is direct viral damage of infected cells. 
CRS is one of the vaccine preventable diseases 
which could result in extended level of 





We are presenting a 9-month-old female infant 
who presented to our clinic with a whitish lesion 
of the left eye since birth. Our assessment and 
investigations are presented here in detail with 
analysis of the case following it.  
On history, she was born at term in a health 
center. The pregnancy and delivery were 
uneventful. The mother did not remember the birth 
weight, but claimed that the child was smaller 
compared to her other children. She had three 
older children who were relatively healthy. 
She was exclusively breast feed for only three 
months and started on half strength cow’s milk 
and gruel made of mixed cereals. She had 
intermittent cough for a long period, which was 
treated locally with antibiotics. Although the 
cough decreased with antibiotics, it recurred 
frequently.  
She did not have interruption of feeding, 
excessive sweating or body swelling. She could 
not sit, crawl or stand without support. She could 
not say mama or papa. She was vaccinated for her 
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age according to the national expanded program of 
immunization. 
The mother had antenatal care follow-up and 
was told that there were no concerns. She was 
screened for available blood test, but not for 
rubella. There was no genetic or fetal 
echocardiography screening.  
On clinical examination, she had no cardio-
respiratory distress with vital signs of heart rate 
130 beats per minute which was full in volume 
and bounding, and a respiratory rate 48 breaths per 
minute which was regular and shallow. She was 
severely wasted and stunted. She had 
microcephaly. She had a whitish lesion over the 
left eye but there no discharge or swelling around 
it. She did not follow objects during evaluation.  
Her chest was clear and resonant, and no 
abnormality was detected. On cardiovascular 
examination, the precordium was silent with the 
apical beat shifting leftward and inferiorly at the 
5
th
 intercostal space lateral to the midclavicular 
line. Normal heart sounds with three out of six 
machinery murmur at the upper left sternal border 
and at the back were heard. The rest of the 
systemic examination showed no further clinically 
significant abnormalities. Ophthalmologic 
evaluation revealed congenital cataract of the left 
eye. 
No abnormality was found on the routine 
blood (complete blood count, peripheral blood 
smear), urine and stool tests. There was no 
available serologic study for rubella. A chest x-ray 
showed symmetrical pulmonary vascular markings 
and increased cardiothoracic ratio of 62.5% 
signaling cardiomegaly.  
Echocardiography revealed normal segmental 
anatomy with normal systemic and pulmonary 
venous connections.  Both The interatrial and 
inerventricular septa were intact. Atrioventricular 
valves were structurally normal with good 
diastolic flow across. There was good 
biventricular function with mild enlargement of 
the left ventricle. Both aortic and pulmonic valves 
were structurally normal with trivial pulmonary 
valve regurgitation. Main Pulmonary Artery and  
Left Pulmonary Artery were good sized, 10.4mm 
(Z-score 0.62) and  5.3mm (Z-score 0.21) and 
with normal flow across respectively. The Right 
Pulmonary Artery was stenosed 3.6mm (Z-score -
2.71) with a pressure gradient across being 
23mmHg. Coronary arteries were normal in origin 
and proximal part.  Left aortic arch with no 
coarctation and pulsatile flow across the 
descending aorta with mild flow reversal was 
seen. There was a Small sized Patent Ductus 
Arteriosus (PDA) (2.6mm) with a left to right flow 
across and pressure gradient across was 30mmHg. 
There was no pericardial or pleural effusion 




Figure 1: Echocardiographic 2D colour image 




               Ethiop J Health Sci.                               Vol. 27, No. 2                      March  2017 
 
 




Figure 2: Echocardiographic 2D image showing the sizes of RPA, LPA, and PDA, Jimma
Table 1: z score values for the main pulmonary artery and its branches, Jimma 2016 
 
Pulmonary Artery Size *Z-score (33) PG across 
RPA 3.6mm -2.71 23mmHg  
LPA 5.3mm 0.21 6mmHg  
MPA 10.4mm 0.62 4mmHg 
PDA 2.6mm  30mmHg  
*Review the reference for the use of the Z-score values and how it was done (12) 
 
The patient was admitted with the assessment of 
severe acute malnutrition (non edematous) + 
clinically confirmed CRS (left eye congenital 
cataract + Congenital heart disease (PDA and 
Proximal Right Pulmonary Artery stenosis) + 
microcephaly). 
Treatment was started for severe acute 
malnutrition according to the national guideline 
for the management of malnutrition. The patient 
was put in follow-up for further study and 
management of the congenital heart disease since 
there was no need for intervention for closure of 
PDA. Such children can be followed as they are 
good candidates for percutaneous ductal closure 
and balloon dilatation of PPS. If they develop 
heart failure, medical treatment can be introduced. 
If medical treatment of congestive heart failure 
fails, the patients will be referred early for closure 
of the PDA (13). 
 
DISCUSSION 
The embryologic development of the heart is at 
the same time as the inner ear and the lens. 
Therefore, damage to the ears and eyes is often 
accompanied by a variety of heart defects (14). 
Thus, infection by rubella at this gestational age 
results in combined infection to those organs.   
Depending on the timing of organogenesis, 
organs involved in the CRS are variable. Infection 
on about the 36
th
 day of gestation leads to 
cataracts, heart defects on the 46
th
  and to defects 
of the inner ear from the 62
nd
 day to the end of 16
th 
gestational week. Infection in the first 1-6 weeks 









  weeks 









  weeks to less than 5% and after 22 
weeks of gestation to no embryopathies (15). 
Multiple and unspecified congenital heart 
diseases may present in relation to CRS. They 
include, but are not limited to, patent ductus 
arteriosis, pulmonic stenosis, aortic stenosis, atrial 
septal defect and ventricular defect. A total of 
32.5% of the cases had cardiac lesions of different 
types (7). O'Donnell gathered information on 88 
individuals with CRS found that 32% had a heart 
condition. Patent Ductus Arteriosus, Atrial or 
Ventricular Septal Defects and Pulmonary 
Stenosis were the most common (16).  Other 
studies had also demonstrated that heart disease 
was one of the leading problems identified in 50% 
of cases (5, 8).  
Patent ductus arteriosus and branch 
pulmonary artery stenosis are the most common 
lesions (17). Other lesions, including pulmonary 
valvular stenosis, aortic valve stenosis, ventricular 
septal defect, tetralogy of Fallot and coarctation of 
the aorta have been also reported (17). Our case 
had also the typical features of CRS with 
peripheral pulmonary stenosis and patent ductus 
arteriosus. 
The presence of PDA with left to right shunt 
can manifest with increased flow across the 
pulmonary artery by then disguises the Doppler 
study for measuring peripheral pulmonary 
stenosis. According to the study by Danilowitz et 
al (18), during cardiac catheterization, the 
reseasrchers were able to confirm only physiologic 
increment in flow rather than actual pulmonary 
stenosis. The study by Maroto et al (19) did not 
identify cases with combined PDA and peripheral 
pulmonary stenosis in the general population. 
It was found from different studies that the 
presence of branch pulmonary artery stenosis 
during the early periods of premature babies was 
transient where complete resolution occurs in the 
first three months of life. This was not the case in 
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conditions with congenital rubella syndrome and 
Allagille syndrome associated peripheral stenosis 
where spontaneous recovery was not expected. 
There were studies which demonstrated 
development of pulmonary stenosis while they try 
to close PDA in premature babies using 
Indomethacine treatment (18-20).   
In conclusion, the presence of cardiac 
manifestations in CRS is significant and can be 
diagnosed with echocardiography as it might not 
be symptomatic. What makes it typical in our case 
is the presentation of combined PDA and 
pulmonary stenosis which need special attention in 
the diagnosis and management of PDA. It is 
recommended that any infant who is suspected to 
have congenital rubella syndrome should undergo 
cardiac evaluation by echocardiography at 
presentation. Because it leads to progressive 
multi-organ deterioration, the clinician should 
remain vigilant of the potential health problems, 
and affected patients should be kept under close 
follow-up. Last, prevention by maintaining a 
vigorous approach of rubella immunizations 
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